Stock listing

ASX:PTX Prescient Therapeutics Limited Share Price

Follow Prescient Therapeutics Limited into a list and get an email when it puts out news.

Share price · ASX:PTX

$0.053 AUD -0.002 (-3.6%)

Close on Oct 30, 2026

Past year +8.2% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.053 – $0.055 AUDOct 30, 2026
Volume
191,792 sharesOct 30, 2026
Market cap
$60.62M AUDAt the close on Oct 30, 2026 · price × 1.14B shares outstanding
52-week range
$0.045 – $0.125 AUDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$60,388 AUDMedian day 599,958 shares · 2 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prescient Therapeutics Limited logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · ASX:PTX · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.053-0.002-3.6%$0.055$0.055$0.053191,792
$0.055+0.003+5.8%$0.052$0.055$0.05217,580
$0.052-0.002-3.7%$0.056$0.056$0.052457,731
$0.054+0.003+5.9%$0.053$0.054$0.052271,970
$0.051-0.003-5.6%$0.054$0.054$0.0501,589,874
$0.054-0.002-3.6%$0.053$0.055$0.052886,759
$0.056-0.001-1.8%$0.061$0.061$0.056312,032
$0.057-0.001-1.7%$0.061$0.061$0.057439,461
$0.058+0.003+5.5%$0.056$0.061$0.056189,701
$0.055-0.003-5.2%$0.057$0.057$0.054350,151
$0.058-0.003-4.9%$0.061$0.061$0.0561,086,998
$0.061-0.004-6.2%$0.066$0.066$0.0611,116,075
$0.0650.0000.0%$0.064$0.066$0.064350,979
$0.065+0.001+1.6%$0.065$0.065$0.064233,555
$0.064-0.002-3.0%$0.065$0.065$0.06432,637
$0.0660.0000.0%$0.066$0.066$0.064736,346
$0.066+0.001+1.5%$0.065$0.066$0.064501,512
$0.0650.0000.0%$0.065$0.065$0.065536,706
$0.065+0.001+1.6%$0.065$0.065$0.064489,319
$0.064-0.002-3.0%$0.066$0.066$0.064245,972
$0.0660.0000.0%$0.064$0.066$0.0641,346,125
$0.066-0.001-1.5%$0.067$0.067$0.0633,110,713
$0.067-0.005-6.9%$0.073$0.073$0.0671,574,217
$0.072+0.002+2.9%$0.072$0.073$0.0711,242,329
$0.070+0.002+2.9%$0.068$0.072$0.068532,870
$0.068+0.001+1.5%$0.066$0.068$0.066101,735
$0.0670.0000.0%$0.067$0.067$0.065291,715
$0.067-0.001-1.5%$0.068$0.068$0.0651,680,441
$0.0680.0000.0%$0.068$0.068$0.0680
$0.0680.0000.0%$0.068$0.068$0.0680
$0.068+0.001+1.5%$0.067$0.073$0.0673,477,311
$0.0670.0000.0%$0.067$0.068$0.067302,958
$0.067+0.001+1.5%$0.067$0.068$0.066598,310
$0.066+0.001+1.5%$0.065$0.069$0.0651,309,998
$0.065-0.003-4.4%$0.068$0.069$0.0651,367,985
$0.068+0.003+4.6%$0.066$0.069$0.0661,522,426
$0.0650.0000.0%$0.067$0.068$0.0641,584,896
$0.0650.0000.0%$0.067$0.069$0.0651,297,488
$0.065-0.003-4.4%$0.070$0.070$0.0651,080,892
$0.0680.0000.0%$0.068$0.071$0.0682,980,678
$0.068+0.001+1.5%$0.068$0.069$0.067528,412
$0.067-0.001-1.5%$0.068$0.068$0.066314,819
$0.0680.0000.0%$0.068$0.068$0.067832,037
$0.068+0.002+3.0%$0.067$0.068$0.066499,072
$0.066-0.001-1.5%$0.067$0.067$0.0641,296,592
$0.067-0.001-1.5%$0.067$0.068$0.066681,432
$0.068+0.001+1.5%$0.068$0.068$0.067840,397
$0.0670.0000.0%$0.067$0.068$0.0661,121,624
$0.067-0.005-6.9%$0.069$0.069$0.0653,559,404
$0.072-0.004-5.3%$0.077$0.077$0.071894,856
$0.076-0.001-1.3%$0.076$0.080$0.075599,958
$0.077-0.002-2.5%$0.080$0.080$0.0752,246,217
$0.079-0.001-1.3%$0.080$0.080$0.078165,661
$0.080-0.005-5.9%$0.085$0.085$0.0801,382,412
$0.085-0.001-1.2%$0.086$0.086$0.084693,160
$0.086+0.003+3.6%$0.084$0.086$0.084609,467
$0.083-0.001-1.2%$0.084$0.085$0.083498,004
$0.084-0.002-2.3%$0.085$0.087$0.084233,969
$0.086+0.001+1.2%$0.085$0.087$0.085173,885
$0.085-0.003-3.4%$0.089$0.089$0.082941,072
$0.088-0.001-1.1%$0.089$0.089$0.085327,039
$0.089-0.002-2.2%$0.089$0.090$0.088186,097
$0.091-0.001-1.1%$0.092$0.093$0.089282,221
$0.092+0.007+8.2%$0.086$0.092$0.0851,978,935
$0.0850.0000.0%$0.088$0.088$0.084650,579
$0.085+0.003+3.7%$0.082$0.087$0.0821,132,171
$0.082+0.001+1.2%$0.081$0.082$0.080362,494
Ticker
ASX:PTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
ASX
Currency
AUD

What changed lately

Latest news

All Prescient Therapeutics Limited news

Financings

  • Share purchase plan of shares

    Sep 23, 2026 · US$3.38M

    Closed: A$4.8M raised · A$0.065 a share

    Use of proceeds: Strengthen cash position and fund continued development of PTX-100 beyond the first Dose Optimisation Committee review

    Closed Sep 23, 2026

  • Private placement of shares

    Sep 23, 2026 · US$845,261

    Closed: A$1.2M raised · A$0.065 a share

    Use of proceeds: Strengthen cash position and fund continued development of PTX-100 beyond the first Dose Optimisation Committee review

    Closed Sep 23, 2026

Read by 6ix AI from the company's releases

Decks

Prescient Therapeutics Limited on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 225 in all · newest Oct 12, 2026 · oldest 2016
Decks
44 decks · latest Oct 14, 2026

Log in to ask 6ix AI your own questions about Prescient Therapeutics Limited.